Cervical Cancer Screening With NGS-HPV Technology Based on Menstrual Blood - Trial NCT06082765
Access comprehensive clinical trial information for NCT06082765 through Pure Global AI's free database. This phase not specified trial is sponsored by Zhongnan Hospital and is currently Recruiting. The study focuses on Cervical Cancer. Target enrollment is 10000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Zhongnan Hospital
Timeline & Enrollment
N/A
Sep 01, 2021
Mar 31, 2028
Primary Outcome
HPV detection in menstrual blood
Summary
Our study is conducted to recruit cervical cancer screening patients to evaluate the
 application value of using high-throughput sequencing technology to detect HPV in menstrual
 blood for cervical cancer screening.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06082765
Non-Device Trial